Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
224.41
+1.77 (0.80%)
Nov 11, 2025, 4:00 PM EST - Market closed
Universal Health Services Market Cap
Universal Health Services has a market cap or net worth of $14.02 billion as of November 12, 2025. Its market cap has increased by 3.66% in one year.
Market Cap
14.02B
Enterprise Value
19.02B
1-Year Change
3.66%
Ranking
Category
Stock Price
$224.41
Market Cap Chart
Since December 1, 1998, Universal Health Services's market cap has increased from $1.76B to $14.02B, an increase of 694.75%. That is a compound annual growth rate of 7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 14.02B | 18.47% |
| Dec 31, 2024 | 11.84B | 13.74% |
| Dec 29, 2023 | 10.41B | 3.42% |
| Dec 30, 2022 | 10.06B | -3.46% |
| Dec 31, 2021 | 10.42B | -10.81% |
| Dec 31, 2020 | 11.69B | -7.00% |
| Dec 31, 2019 | 12.56B | 16.52% |
| Dec 31, 2018 | 10.78B | 0.23% |
| Dec 29, 2017 | 10.76B | 4.31% |
| Dec 30, 2016 | 10.31B | -12.35% |
| Dec 31, 2015 | 11.77B | 6.86% |
| Dec 31, 2014 | 11.01B | 37.89% |
| Dec 31, 2013 | 7.99B | 69.91% |
| Dec 31, 2012 | 4.70B | 25.28% |
| Dec 30, 2011 | 3.75B | -11.17% |
| Dec 31, 2010 | 4.22B | 40.72% |
| Dec 31, 2009 | 3.00B | 57.68% |
| Dec 31, 2008 | 1.90B | -30.77% |
| Dec 31, 2007 | 2.75B | -8.60% |
| Dec 29, 2006 | 3.01B | 17.92% |
| Dec 30, 2005 | 2.55B | -1.74% |
| Dec 31, 2004 | 2.60B | -16.65% |
| Dec 31, 2003 | 3.11B | 14.07% |
| Dec 31, 2002 | 2.73B | 6.58% |
| Dec 31, 2001 | 2.56B | -23.26% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |